China Pharma Holdings Inc. Reports Recent Stock Performance

China Pharma Holdings, Inc., a company operating within the health care sector, specifically in the pharmaceutical industry, has recently been in the spotlight due to its stock performance. The company, based in Haikou, China, focuses on developing and manufacturing pharmaceutical products aimed at treating high-incidence and high-mortality diseases. These products are marketed to hospitals and private sellers within the People’s Republic of China.

As of June 16, 2025, the close price of China Pharma Holdings’ stock was recorded at $1.83. This figure is part of a broader trend observed over the past year. The company’s stock reached a 52-week high of $3.40 on January 6, 2025, and a 52-week low of $1.20 on April 8, 2025. These fluctuations highlight the volatility in the stock’s performance over the past year.

China Pharma Holdings is listed on the NYSE American stock exchange, and its market capitalization stands at $5,190,000 USD. The company’s operations are primarily focused on the Chinese market, where it aims to address significant health challenges through its pharmaceutical products.

For more information about China Pharma Holdings, Inc., interested parties can visit their website at www.chinapharmaholdings.com . The company continues to play a vital role in the health care sector by targeting critical medical conditions with its product offerings.